These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1359635)

  • 21. Cyclosporin and sulfasalazine combination in the treatment of early rheumatoid arthritis.
    Rojkovich B; Hodinka L; Bálint G; Szegedi G; Varjú T; Tamási L; Molnár E; Szilágyi M; Szocsik K
    Scand J Rheumatol; 1999; 28(4):216-21. PubMed ID: 10503557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical pharmacokinetics of sulphasalazine.
    Das KM; Dubin R
    Clin Pharmacokinet; 1976; 1(6):406-25. PubMed ID: 15752
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of age and acetylator phenotype on the pharmacokinetics of sulfasalazine in patients with rheumatoid arthritis.
    Taggart AJ; McDermott BJ; Roberts SD
    Clin Pharmacokinet; 1992 Oct; 23(4):311-20. PubMed ID: 1356683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Psoriasis-like skin reaction in a patient with rheumatoid arthritis after sulphasalazine therapy.
    Bliddal H; Stangerup M
    Clin Rheumatol; 1991 Jun; 10(2):178-80. PubMed ID: 1680596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predisposing factors in sulphasalazine-induced systemic lupus erythematosus.
    Gunnarsson I; Kanerud L; Pettersson E; Lundberg I; Lindblad S; Ringertz B
    Br J Rheumatol; 1997 Oct; 36(10):1089-94. PubMed ID: 9374926
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A study to determine the active moiety of sulphasalazine in rheumatoid arthritis.
    Neumann VC; Taggart AJ; Le Gallez P; Astbury C; Hill J; Bird HA
    J Rheumatol; 1986 Apr; 13(2):285-7. PubMed ID: 2873245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sulphasalazine for rheumatoid arthritis. Studies on dose, acetylator phenotype and efficacy.
    Amos RS; Bax DE; Greaves MS
    Drugs; 1986; 32 Suppl 1():58. PubMed ID: 2877855
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of methotrexate alone or in combination with sulphasalazine on the production and circulating concentrations of cytokines and their antagonists. Longitudinal evaluation in patients with rheumatoid arthritis.
    Barrera P; Haagsma CJ; Boerbooms AM; Van Riel PL; Borm GF; Van de Putte LB; Van der Meer JW
    Br J Rheumatol; 1995 Aug; 34(8):747-55. PubMed ID: 7551660
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The indications for the use of salazosulfapyridine in rheumatoid arthritis patients].
    Taneichi K; Baba Y; Sakai I; Shibaki H
    Ryumachi; 1994 Aug; 34(4):744-51. PubMed ID: 7974025
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sulphasalazine-induced autoimmune abnormalities in patients with rheumatic disease.
    Laversuch CJ; Collins DA; Charles PJ; Bourke BE
    Br J Rheumatol; 1995 May; 34(5):435-9. PubMed ID: 7788172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sulphasalazine therapy in rheumatoid arthritis: qualitative changes in lymphocytes and correlation with clinical response.
    Samanta A; Webb C; Grindulis KA; Fleming J; Sheldon PJ
    Br J Rheumatol; 1992 Apr; 31(4):259-63. PubMed ID: 1348199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sulphasalazine in the treatment of rheumatoid arthritis: relationship of dose and serum levels to efficacy.
    Pullar T; Hunter JA; Capell HA
    Br J Rheumatol; 1985 Aug; 24(3):269-76. PubMed ID: 2861876
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toxicity of sulphasalazine in rheumatoid arthritis. Possible protective effect of rheumatoid factors and corticosteroids.
    Gran JT; Myklebust G
    Scand J Rheumatol; 1993; 22(5):229-32. PubMed ID: 7901898
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination of sulphasalazine and methotrexate versus the single components in early rheumatoid arthritis: a randomized, controlled, double-blind, 52 week clinical trial.
    Haagsma CJ; van Riel PL; de Jong AJ; van de Putte LB
    Br J Rheumatol; 1997 Oct; 36(10):1082-8. PubMed ID: 9374925
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sulphasalazine for rheumatoid arthritis: toxicity in 774 patients monitored for one to 11 years.
    Amos RS; Pullar T; Bax DE; Situnayake D; Capell HA; McConkey B
    Br Med J (Clin Res Ed); 1986 Aug; 293(6544):420-3. PubMed ID: 2874863
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treating rheumatoid arthritis early with disease modifying drugs reduces joint damage: a randomised double blind trial of sulphasalazine vs diclofenac sodium.
    Choy EH; Scott DL; Kingsley GH; Williams P; Wojtulewski J; Papasavvas G; Henderson E; Macfarlane D; Erhardt C; Young A; Plant MJ; Panayi GS
    Clin Exp Rheumatol; 2002; 20(3):351-8. PubMed ID: 12102471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sulphasalazine therapy in rheumatoid arthritis. A two-year study and follow-up of clinical results.
    Georgescu C
    Rom J Intern Med; 1992; 30(2):127-32. PubMed ID: 1353901
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination of methotrexate and sulphasalazine in patients with rheumatoid arthritis: pharmacokinetic analysis and relationship to clinical response.
    Haagsma CJ; Russel FG; Vree TB; Van Riel PL; Van de Putte LB
    Br J Clin Pharmacol; 1996 Aug; 42(2):195-200. PubMed ID: 8864317
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low dose desensitisation does not reduce the toxicity of sulphasalazine in rheumatoid arthritis.
    McInnes IB; Porter D; Murphy EA; Thomson EA; Madhok R; Hunter JA; Pullar T; Capell HA
    Ann Rheum Dis; 1996 May; 55(5):328-30. PubMed ID: 8660109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of sulphasalazine on faecal flora in patients with rheumatoid arthritis: a comparison with penicillamine.
    Neumann VC; Shinebaum R; Cooke EM; Wright V
    Br J Rheumatol; 1987 Oct; 26(5):334-7. PubMed ID: 2889501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.